Escalon Medical Corp
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or … Read more
Escalon Medical Corp (ESMC) - Total Liabilities
Latest total liabilities as of September 2025: $2.91 Million USD
Based on the latest financial reports, Escalon Medical Corp (ESMC) has total liabilities worth $2.91 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Escalon Medical Corp - Total Liabilities Trend (2000–2025)
This chart illustrates how Escalon Medical Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Escalon Medical Corp Competitors by Total Liabilities
The table below lists competitors of Escalon Medical Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Akash Infra-Projects Limited
NSE:AKASH
|
India | ₹1.23 Billion |
|
Graphene & Solar Technologies Limited
PINK:GSTX
|
USA | $3.14 Million |
|
Leveljump Healthcare Corp
OTCQB:JMPHF
|
USA | $15.49 Million |
|
Hutchison Telecommunications (Australia) Ltd
AU:HTA
|
Australia | AU$51.03 Million |
|
Commander Resources Ltd
PINK:CMDRF
|
USA | $115.83K |
|
SUREFIRE RES
F:GBL
|
Germany | €12.33 Million |
|
Blue Chip India Limited
NSE:BLUECHIP
|
India | ₹56.49 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Escalon Medical Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.73 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Escalon Medical Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Escalon Medical Corp (2000–2025)
The table below shows the annual total liabilities of Escalon Medical Corp from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $3.08 Million | +4.40% |
| 2024-06-30 | $2.95 Million | -12.59% |
| 2023-06-30 | $3.37 Million | -8.69% |
| 2022-06-30 | $3.69 Million | -12.52% |
| 2021-06-30 | $4.22 Million | +0.29% |
| 2020-06-30 | $4.21 Million | +42.00% |
| 2019-06-30 | $2.97 Million | -1.64% |
| 2018-06-30 | $3.01 Million | -20.68% |
| 2017-06-30 | $3.80 Million | +4.99% |
| 2016-06-30 | $3.62 Million | +1.71% |
| 2015-06-30 | $3.56 Million | -15.11% |
| 2014-06-30 | $4.19 Million | +21.76% |
| 2013-06-30 | $3.44 Million | -62.19% |
| 2012-06-30 | $9.11 Million | -17.71% |
| 2011-06-30 | $11.06 Million | +11.30% |
| 2010-06-30 | $9.94 Million | -21.20% |
| 2009-06-30 | $12.62 Million | +71.32% |
| 2008-06-30 | $7.36 Million | +31.24% |
| 2007-06-30 | $5.61 Million | +1.19% |
| 2006-06-30 | $5.54 Million | +0.27% |
| 2005-06-30 | $5.53 Million | -7.77% |
| 2004-06-30 | $6.00 Million | -24.59% |
| 2003-06-30 | $7.95 Million | -18.19% |
| 2002-06-30 | $9.72 Million | -16.87% |
| 2001-06-30 | $11.69 Million | +2.28% |
| 2000-06-30 | $11.43 Million | -- |